Informed consent: Issues and challenges

被引:179
作者
Nijhawan, Lokesh P. [1 ]
Muddukrishna, B. S. [3 ]
Bhat, K. M. [3 ]
Bairy, K. L. [4 ]
Udupa, N. [2 ]
Musmade, Prashant B. [3 ,4 ]
Janodia, Manthan D. [2 ]
机构
[1] Manipal Univ, Dept Adv Pharmaceut Studies, Manipal, Karnataka, India
[2] Manipal Univ, Dept Pharm Management, Manipal, Karnataka, India
[3] Manipal Univ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut Qual Assurance, Manipal, Karnataka, India
[4] Manipal Univ, Kasturba Med Coll, Manipal 576104, Karnataka, India
关键词
Human subjects; informed consent; institutional review board;
D O I
10.4103/2231-4040.116779
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Informed consent is an ethical and legal requirement for research involving human participants. It is the process where a participant is informed about all aspects of the trial, which are important for the participant to make a decision and after studying all aspects of the trial the participant voluntarily confirms his or her willingness to participate in a particular clinical trial and significance of the research for advancement of medical knowledge and social welfare. The concept of informed consent is embedded in the principles of Nuremberg Code, The Declaration of Helsinki and The Belmont Report. Informed consent is an inevitable requirement prior to every research involving human being as subjects for study. Obtaining consent involves informing the subject about his or her rights, the purpose of the study, procedures to be undertaken, potential risks and benefits of participation, expected duration of study, extent of confidentiality of personal identification and demographic data, so that the participation of subjects in the study is entirely voluntary. This article provides an overview of issues in informed consent: The obligations of investigator, sponsor and Institutional Review Board to protect rights and welfare of human research subjects. It discusses about the basic elements of informed consent and the process to be followed while obtaining informed consent. Some of the circumstances under which informed consent can be waived and ethical challenges faced by physicians in obtaining informed consent from subjects are also highlighted in this article.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 17 条
[1]  
[Anonymous], 1996, BRIT MED J, V313, P1448
[2]  
[Anonymous], 2009, INVESTIGATOR RESPONS
[3]  
[Anonymous], ETH PRINC MED RES IN
[4]  
[Anonymous], 1979, BELM REP ETH PRINC G
[5]  
[Anonymous], CFR CODE FEDERAL REG
[6]  
[Anonymous], RES INVOLVING CHILDR
[7]  
[Anonymous], 1996, INT C HARM TECHN REQ
[8]  
Berry IR, 2005, PHARM REGULATORY PRO
[9]   Community based trials and informed consent in rural north India [J].
DeCosta, A. ;
D'Souza, N. ;
Krishnan, S. ;
Chhabra, M. S. ;
Shihaam, I. ;
Goswami, K. .
JOURNAL OF MEDICAL ETHICS, 2004, 30 (03) :318-323
[10]  
Escobedo C, ETHICAL ISSUES INFOR